arrow
M

Masaru Nakagawa

nihon university school of medicine
H指数:34
被引数:6,631

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal changes in gut microbial evenness and dominance during anti-CD20-containing chemoimmunotherapy with concurrent trimethoprim–sulfamethoxazole prophylaxis in patients with B-cell lymphoma

接受含抗CD20化疗免疫疗法并联合使用甲氧苄啶-磺胺甲噁唑预防的B细胞淋巴瘤患者肠道微生物群均匀度和优势度的纵向变化

2026-10-290
OA
Evaluation of the UK Myeloma Research Alliance risk profile in transplant-ineligible multiple myeloma patients treated with novel agents

评估英国骨髓瘤研究联盟风险特征在移植不适用的新型药物治疗的复发性骨髓瘤患者中的应用

2026-09-060
PRE
Geriatric assessment-based therapy for older patients with diffuse large B-cell lymphoma: results of a two-decade clinical experience

基于老年评估的治疗方案在弥漫性大B细胞淋巴瘤老年患者中的应用:二十年临床经验的结果

2026-04-250
OAAI
Favorable response to daratumumab combination therapy in patients with multiple myeloma with an immature phenotype: a report from the J-CHARGE study group

达拉妥单抗联合疗法在具有不成熟表型的多发性骨髓瘤患者中的良好疗效:J-CHARGE研究组的报告

2025-11-010
PRE
Investigation of early mortality in the patients with newly diagnosed multiple myeloma: insights from a real-world cohort using J-CHAEGE-MM database

新诊断多发性骨髓瘤患者早期死亡的研究:来自使用J-CHAEGE-MM数据库的真实世界队列的见解

2025-10-010
PRE
Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera

引入加热不燃烧烟草可改善吸烟者红细胞增多症和红细胞增多症患者的红细胞压积及与吸烟相关的症状。

2025-05-280
OA
Pirarubicin-based intensive chemotherapy followed by consolidative high-dose chemotherapies for peripheral T-cell lymphomas: A noncomparative phase 2 study
2022-07-080
PRE